Have investors soured on mRNA biotechs? How will Vinay Prasad approach his role at the Food and Drug Administration the second time around? And how do you pronounce “bronchiectasis”?

We address all that and more on this week’s episode of “The Readout LOUD.” We discuss the sudden return of Prasad and the mixed prospects for mRNA. Then, we invite STAT fellow Marissa Russo on to discuss the alternatives to animal testing, and why they’re the subject of hot debate among scientists.

For more on Prasad’s return, go here ; for a “Matt’s Take” on Prasad, go here ; for the latest on investors’ attitudes toward mRNA, go here ; to read about the debate around animal testing alternatives, go here , for more on Insmed’s drug approval, go here ; and to read more about the layoffs at Dewpoint

See Full Page